Hb AS

Hb AS

abbr.
hemoglobin A and hemoglobin S (heterozygous state) (the sickle cell trait)

Patient discussion about Hb AS

Q. Please precribe for me the possible medicine (treatment) for sickle cells. Secondly, my boy lost hearing at 4 1- I need to know how sickle cells can be treated. 2- My boy just surprisingly lost his abillity to hear anything at the age of 4.

A. wow...you are going through some hard times...it's the hardest thing in the world seeing your children in pain. loosing his hearing could be caused by clots that were formed and destroyed the ear nerve. but it's unlikely it happened in both ears...so i would check it out. and about treatment- there are a variety of treatments, so i found a web site with them all. and even some that are still in research: http://www.nhlbi.nih.gov/health/dci/Diseases/Sca/SCA_Treatments.html

More discussions about Hb AS
References in periodicals archive ?
Common Hb traits such as Hb AS and Hb AC, however, do not interfere with the CE-HPLC Hb [A.
An increase in the frequency of Hb monitoring during an acute event can help highlight a trend of increasing Hb as the underlying condition is resolved, thereby allowing a timely decrease in the Epoetin alfa dose to ensure that Hb levels do not exceed 12 g/dL.
1c] and is characterized by the reversible binding of glucose to Hb as a Schiff base (1).
Thus, ongoing or periodic use of Hct to assess anemia outcomes may lead to inconsistent and inaccurate results; the NKFK/DOQI[TM] guidelines recommend using Hb as the primary means of quantifying the level of anemia in patients with ESRD (National Kidney Foundation, 2001).
n) Hb AS, Hb SS, Hb SC, Hb S/ [beta]-thal, Hb SE, Hb SG-Philadelphia, Hb SO-Arab, Hb SJ-Toronto, and Hb SFukuyama included.
Thus, ongoing or periodic use of Hct to assess anemia outcomes may lead to inconsistent and inaccurate results; the NKF K/DOQI[TM] guidelines recommend using Hb as the primary means of quantifying the level of anemia in patients with ESRD (NKF-K/DOQI, 200l).
No clinically significant interference attributable to Hb AC or Hb AS was seen with the Nycocard, Synchron CX7, VARIANT GHb, and VARIANT II methods (Table 1).
A subset of samples with Hb AS (n = 10) was analyzed by Diamat HPLC using two different column series (P and R); all other samples were analyzed using a
Our data for Hb AS samples with the Diamat method were not consistent with previous results (5, 6).
Recently, the effects of Hb AC and Hb AS on one gHb immunoassay method were assessed (5).
The mean percentage of the Hb 5 in samples with Hb AS was 38% (range, 25-41%), and the mean percentage of Hb C in samples with Hb AC was 38% (range, 29-41%).
2 summarizes the most important data, namely, the total concentration of Hb as a measure of the severity of the disease and the concentration of Hb F.